DataString Consulting Company Logo
DataString Consulting Company Logo
Digital Neuro Biomarkers Market
Home»Top Market Reports»Digital Neuro Biomarkers Market

Digital Neuro Biomarkers Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1803002, Published - December 2024

Segmented in Methodology (Technological Devices, Software Analytics), Biomarker Type (Genetic, Imaging, Biochemical, Cognitive), Application, End-Use and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Digital Neuro Biomarkers
Market Outlook

Digital Neuro Biomarkers signify a development in the field of healthcare. The market, for Digital neuro biomarkers was estimated at $742.7 million in 2024. It is anticipated to increase to $2609.7 million by 2030 with projections indicating a growth to around $7437.2 million by 2035. This expansion represents a compound annual growth rate (CAGR) of 23.3% over the forecast period. Marking the dawn of a new era in neurology. Its portability and transformative capabilities hold the promise of a change enabling widespread real time health monitoring and predictive neuroanalysis akin to the prevalence of smartphones, in todays world.


Digital Neuro Biomarkers utilize intelligence and neuroimaging technologies to observe and interpret human neurological health patterns efficiently without intrusion by gathering significant neurological data via digital platforms – thus challenging conventional neurology boundaries.


Market Size Forecast & Key Insights

2019
$742M2024
2029
$6.0B2034

Absolute Growth Opportunity = $5.3B

The Digital Neuro Biomarkers market is projected to grow from $742.7 million in 2024 to $6.03 billion in 2034. This represents a CAGR of 23.3%, reflecting rising demand across Clinical Neurodegeneration Monitoring, Cognitive Function Assessment and Mental Health.

The Digital Neuro Biomarkers market is set to add $5.3 billion between 2024 and 2034, with manufacturer targeting Imaging & Biochemical Biomarker Type projected to gain a larger market share.

With Advancements in neuroimaging technologies, and Increasing incidence of neurological disorders, Digital Neuro Biomarkers market to expand 712% between 2024 and 2034.

Opportunities in the Digital Neuro Biomarkers Market

Telemedicine and Remote Monitoring

The widespread use of telemedicine significantly increased due, to the impact of the COVID 19 outbreak worldwide.

Integration of Artificial Intelligence and Advancement in Wearable Technology

AI has become an advancement in this century and is now applicable across various important industries. As, for digital neuro biomarkers research AI can analyze patterns. Streamline the intricate human biological data to enhance assessment methods and diagnostic precision.

The increasing worldwide trend towards prioritizing health and fitness has sparked interest in wearable technology devices. These gadgets have the potential to revolutionize the collection of digital neuro biomarkers by offering information on a range of health metrics. Furthermore they could be utilized to identify neurological abnormalities providing early indications of conditions, like seizures, strokes and neurodegenerative diseases.

Growth Opportunities in North America and Europe

Europe Outlook

In Europe's digital neuro biomarkers sector is experiencing an influence from the increasing number of elderly people with neurological conditions and the active involvement of regional governments in healthcare digitalization efforts. The competition in this field is both moderate and dynamic as it involves a blend of international corporations and robust local entities. An area with growth prospects is the emerging economies of Eastern Europe which offer a significant opportunity, for market expansion.

North America Outlook

In the digital neuro biomarkers sector in North America is experiencing growth due to advancements in machine learning algorithms used in medical applications and strong healthcare infrastructure supporting the adoption of these innovations. North America has competition from major global players such, as Apple

North America Outlook

In the digital neuro biomarkers sector in North America is experiencing growth due to advancements in machine learning algorithms used in medical applications and strong healthcare infrastructure supporting the adoption of these innovations. North America has competition from major global players such, as Apple

Europe Outlook

In Europe's digital neuro biomarkers sector is experiencing an influence from the increasing number of elderly people with neurological conditions and the active involvement of regional governments in healthcare digitalization efforts. The competition in this field is both moderate and dynamic as it involves a blend of international corporations and robust local entities. An area with growth prospects is the emerging economies of Eastern Europe which offer a significant opportunity, for market expansion.

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, United Kingdom, China, Japan are expected to grow at 22.4% to 32.6% CAGR

2

Emerging Markets : Israel, Singapore, United Arab Emirates are expected to grow at 17.5% to 24.2% CAGR

Market Analysis Chart

The rise in conditions like Alzheimers disease and Parkinsons disease worldwide and the growing use of data driven decision making in healthcare are key factors driving the demand for Digital Neuro Biomarkers in the market today. Furthermore advancements in technology like gadgets and smartphones have made it easier to gather data on neurological health without invasion. Moreover the significant advancements, in AI and machine learning methods have made it possible to analyze this gathered data effectively fuel ling the markets growth.

Recent Developments and Technological Advancement

December 2024

Biometrics Ltd has unveiled a digital platform for neuro biomarkers to identify early signs of neuron damage, in neurodegenerative diseases.

October 2024

CognoTech utilized intelligence and machine learning methods to enhance the precision of their digital neuro biomarker instruments.

July 2024

NeuroScanCorp ha brevettato un processo di identificazione dei biomarcatori digitali non invasivo per la diagnosi dei disturbi mentali.

In times there have been significant advancements in the realm of Digital Neuro Biomarkers due to the integration of machine learning and AI technologies. This progress has led to improved detection, prediction and intervention for neurological disorders when compared to conventional approaches. A key factor contributing to this progress is the growing partnerships between healthcare and technology firms, with the goal of transforming the field of neuro health.

Impact of Industry Transitions on the Digital Neuro Biomarkers Market

As a core segment of the Healthcare IT industry, the Digital Neuro Biomarkers market develops in line with broader industry shifts. Over recent years, transitions such as Machine Learning Revolutionizing Predictive Power and Wearable Technology Amplifying Data Collection have redefined priorities across the Healthcare IT sector, influencing how the Digital Neuro Biomarkers market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Machine Learning Revolutionizing Predictive Power:

The use of machine learning and artificial intelligence in the Digital Neuro Biomarkers sector has greatly enhanced its ability to make predictions. These cutting edge technologies aid, in the precise detection and categorization of disease patterns leading to more efficient diagnosis and treatment decisions. Such advancements are set to revolutionize the methods of assessing and predicting diseases

2

Wearable Technology Amplifying Data Collection:

The growing popularity of technology is transforming the Digital Neuro Biomarkers market in significant ways as well. Progress in wearables has made it easier to gather data from patients continuously. Without invasiveness in real time. This advancement opens up avenues, for tailored healthcare by improving disease control and patient results.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Healthcare IT industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Healthcare IT industry cascade into the Digital Neuro Biomarkers market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Advancements in Neuroimaging Technologies, and Widespread Adoption of AI & Machine Learning

The new advancements in neuroimaging technologies offer, in depth understandings of the brains structure and operations leading to recognition of neuro biomarkers that drive market growth.
Incorporating intelligence and machine learning into the field of neurology has also revolutionized the way diagnoses are also made. The utilization of these technologies allows for the analysis of intricate neurological data promoting precise identification and assessment of neurological biomarkers.
The increase in the occurrence of conditions such as Alzheimers disease and Parkinsons disease has also led to a demand, for digital neuro biomarkers to forecast the development and advancement of these illnesses and facilitate prompt intervention and improved patient treatment.

Restraint: Lack of Technological Infrastructure

The digital neuro biomarker sector relies on technological systems for data gathering and analysis purposes as well as for storage capabilities. Any deficiencies, in these aspects could hinder market expansion significantly in underdeveloped regions.

Challenge: Regulatory and Ethical Challenges

Strict regulations and ethical considerations present challenges for the digital neuro biomarker market as well. Getting the required approvals for digital neuro biomarker technologies, from regulatory agencies can be a lengthy and costly process. Additionally using these technologies raises concerns related to patient confidentiality data protection and consent which could impede market growth.

Supply Chain Landscape

Research & Development

Biogen

Koninklijke Philips

Digital Device & Software Creation

Apple

Google

Clinical Validation
Roche / Pfizer
End-User Applications
Healthcare Providers / Pharmaceutical and Research Institutes
Research & Development

Biogen

Koninklijke Philips

Digital Device & Software Creation

Apple

Google

Clinical Validation

Roche

Pfizer

End-User Applications

Healthcare Providers

Pharmaceutical and Research Institutes

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading ProvidersProvider Strategies
Digital Cognitive Health Assessment
Healthcare
Cogstate
Providing solutions to measure cognition for clinical trials, improve mental acuity and clinical care
Early Detection of Neurological Disorders
Mental Health & Neurology
Winterlight
Leveraging natural speech patterns to detect and track the progression of neurological disorders
Personalized Neurotherapy
Therapeutic sector
Mindstrong
Offers personalized therapeutic insights based on unique biomarker profiles
Societal Stress Mapping
Population Health
Ellipsis Health
Implementing large scale societal stress mapping using vocal biomarkers to measure mental health state

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Digital Neuro Biomarkers market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Digital Neuro Biomarkers in Clinical Neurodegeneration Monitoring, Cognitive Function Assessment and Mental Health

Clinical Neurodegeneration Monitoring

Digital Neuro Biomarkers are essential for monitoring and tracking conditions like Alzheimers and Parkinsons diseases accurately and continuously without invasion to improve diagnosis accuracy and treatment effectiveness in patients neurological state. Moreover ongoing improvements promote discovery and preventive healthcare methods with established players such as Neurotrack and Biogen, in the industry.

Cognitive Function Assessment

By incorporating AI methods into the mix Digital Neuro Biomarkers enable the evaluation of abilities, which proves valuable in assessing brain health detecting cognitive deficiencies and enhancing tailored treatment strategies. Instruments developed by companies such as Cognixtion and Cambridge Cognition aid medical professionals in comprehending subtle shifts, in behavior presenting an exceptional chance to refine therapies like never before.

Mental Health

Digital Neuro Biomarkers have been widely utilized in the management and monitoring of health issues for their valuable role in providing an objective assessment of brain health without relying solely on subjective self reports. Its implementation has notably improved the precision of diagnoses and the effectiveness of treatments resultinig in overall mental health outcomes. Established market players such as Headspace Health and Mindstrong are leveraging these tools to pioneer novel approaches, in mental healthcare.

Digital Neuro Biomarkers vs. Substitutes:
Performance and Positioning Analysis

Digital Neuro Biomarkers offer analysis and accurate information without the need for invasive procedures and delayed results seen in traditional methods​ ​The non invasive approach of Digital Neuro Biomarkers positions it for significant growth, in the field of neuroscience research​

Digital Neuro Biomarkers
  • Biochemical Neuro Biomarkers /
  • Bioimaging techniques
    High Accuracy, Non-invasive nature
    High Costs, Lack of Regulatory Framework
    Advanced data collection, robust analytical tools
    Limited accessibility, high costs

Digital Neuro Biomarkers vs. Substitutes:
Performance and Positioning Analysis

Digital Neuro Biomarkers

  • High Accuracy, Non-invasive nature
  • High Costs, Lack of Regulatory Framework

Biochemical Neuro Biomarkers / Bioimaging techniques / Clinical Neurological Examinations

  • Advanced data collection, robust analytical tools
  • Limited accessibility, high costs

Digital Neuro Biomarkers offer analysis and accurate information without the need for invasive procedures and delayed results seen in traditional methods​ ​The non invasive approach of Digital Neuro Biomarkers positions it for significant growth, in the field of neuroscience research​

Loading...

Research Methodology

This market research methodology defines the Digital Neuro Biomarkers market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Healthcare IT ecosystem, we analyze Digital Neuro Biomarkers across Drug Discovery & Development, Personalized Medicine, and Disease Risk Assessment Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Neurotrack, Mindstrong Health, and Cognizomics by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Research & Development, Digital Device & Software Creation, and Clinical Validation. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Healthcare IT revenues to estimate the Digital Neuro Biomarkers segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Research & Development (Biogen, Koninklijke Philips), Digital Device & Software Creation (Apple, Google), and Clinical Validation. Our parallel substitute analysis examines Biochemical Neuro Biomarkers, Bioimaging techniques, and Clinical Neurological Examinations, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Neurotrack, Mindstrong Health, and Cognizomics, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Digital Neuro Biomarkers market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Digital Neuro Biomarkers Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 915 million
Revenue Forecast in 2034USD 6.03 billion
Growth RateCAGR of 23.3% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 2024742 million
Growth OpportunityUSD 5.3 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD million and Industry Statistics
Market Size 2024742 million USD
Market Size 20271.39 billion USD
Market Size 20292.12 billion USD
Market Size 20302.61 billion USD
Market Size 20346.03 billion USD
Market Size 20357.44 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredMethodology, Biomarker Type, Application, End-Use
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledNeurotrack, Mindstrong Health, Cognizomics, NeuraMetrix, Altoida Inc, PharmaCog, Winterlight labs Inc, Nervanix, Verily Life Sciences, Lundbeck, Biogen and ElMindA
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Digital Neuro Biomarkers Market Size, Opportunities & Strategic Insights, by Methodology

4.1Technological Devices
4.2Software Analytics
Chapter 5

Digital Neuro Biomarkers Market Size, Opportunities & Strategic Insights, by Biomarker Type

5.1Genetic
5.2Imaging
5.3Biochemical
5.4Cognitive
Chapter 6

Digital Neuro Biomarkers Market Size, Opportunities & Strategic Insights, by Application

6.1Drug Discovery & Development
6.2Personalized Medicine
6.3Disease Risk Assessment
6.4Forensic Science
Chapter 7

Digital Neuro Biomarkers Market Size, Opportunities & Strategic Insights, by End-Use

7.1Hospitals
7.2Clinical Laboratories
7.3Diagnostic Centers
Chapter 8

Digital Neuro Biomarkers Market, by Region

8.1North America Digital Neuro Biomarkers Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Digital Neuro Biomarkers Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Digital Neuro Biomarkers Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Digital Neuro Biomarkers Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Digital Neuro Biomarkers Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Digital Neuro Biomarkers Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Neurotrack
9.2.2Mindstrong Health
9.2.3Cognizomics
9.2.4NeuraMetrix
9.2.5Altoida Inc
9.2.6PharmaCog
9.2.7Winterlight labs Inc
9.2.8Nervanix
9.2.9Verily Life Sciences
9.2.10Lundbeck
9.2.11Biogen
9.2.12ElMindA